Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7196/AJTCCM.2020.v26i3.106 http://scihub22266oqcxt.onion/10.7196/AJTCCM.2020.v26i3.106 C7346767!7346767!34235424     free     free     free       Afr+J+Thorac+Crit+Care+Med 2020 ; 26 (3): ä Nephropedia Template TP {{tp|p=34235424|t=2020. The use of corticosteroids for COVID-19 infection |pdf=|usr=}}{{34235424}} gab.com Text The use of corticosteroids for COVID-19 infection JO: Afr J Thorac Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=34235424 #FOAvip The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detrimental effects of corticosteroid therapy in general viral respiratory infections and, in particular, COVID-19 infections. While the definitive answer may need to await the results of ongoing randomised, controlled trials recent studies suggest that corticosteroid use in COVID-19 cases with hypoxaemia may benefit from low-dose corticosteroid therapy. Twit Text FOAVip The use of corticosteroids for COVID-19 infection ????Afr J Thorac Crit Care Med http://www.kidney.de/pget.php?&tw=1&pmid=34235424 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34235424 #FOAvip English Wikipedia <ref>{{Cite pmid|34235424}}</ref> The use of corticosteroids for COVID-19 infection #MMPMID34235424 Richards GA; Feldman C Afr J Thorac Crit Care Med 2020[]; 26 (3): ä PMID34235424show ga The SARS-CoV-2 pandemic is continuing relentlessly in many parts of the world and has resulted in the outpouring of literature on various aspects of the infection, including studies and recommendations regarding the optimal treatment of infected patients. Not surprisingly, the use of corticosteroids in the management of such patients has featured prominently in many of these publications. There is considerable debate in the literature as to the likely benefits, as well as the potential detrimental effects of corticosteroid therapy in general viral respiratory infections and, in particular, COVID-19 infections. While the definitive answer may need to await the results of ongoing randomised, controlled trials recent studies suggest that corticosteroid use in COVID-19 cases with hypoxaemia may benefit from low-dose corticosteroid therapy. äThe use of corticosteroids for COVID-19 infection (epmc).pdf DeepDyve Pubget Overpricing